{"text_format":"3","workbook":"xls","n_sheets":3,"sheets":["COVID_VaccineRnD","VaccineRnD legend","APAs"],"not_rendered":{"external_links":1,"defined_names":3},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"COVID_VaccineRnD","index":0,"n_rows":175,"n_cols":9,"rows_kept":175,"flags":["formulas_cached_only"]}
["Funder","Funder_Country","Recipient_country","Recipient_lvl_1","Value_USD","USD_million","Funding_type","Date announced","URL"]
["Advantech Capital","China","China","SinoVac",{"v":7500000,"d":"7,500,000.00"},{"v":7.5,"d":"7.50"},"Direct funding","2020-05-22","https://www.businesswire.com/news/home/20200522005096/en/Sinovac-Secures-15-Million-Funding-Accelerate-COVID-19"]
["ADX Foundation","United States of America","Norway","CEPI",{"v":100000,"d":"100,000.00"},{"v":0.1,"d":"0.10"},"Funding to intermediary","2020-06-24","http://www.globenewswire.com/news-release/2020/06/24/2052705/0/en/ADX-Labs-donates-100-000-to-advance-COVID-19-vaccine-research.html"]
["Aurizon","Australia","Australia","University of Queensland",{"v":176205.75,"d":"176,205.75"},0.17620575,"Direct funding","2020-04-17","https://www.aurizon.com.au/news/2020/aurizon-donates-$250-000-to-university-of-queensland-to-fast-track-development-of-covid-19-vaccine"]
["Australian government","Australia","Australia","University of Melbourne",{"v":2114469,"d":"2,114,469.00"},{"v":2.114469,"d":"2.11"},"Direct funding","2020-09-20","https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/further-investment-in-three-new-australian-covid-19-vaccine-research-projects"]
["Australian government","Australia","Australia","University of Sydney",{"v":2114469,"d":"2,114,469.00"},{"v":2.114469,"d":"2.11"},"Direct funding","2020-09-20","https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/further-investment-in-three-new-australian-covid-19-vaccine-research-projects"]
["Australian government","Australia","Australia","Vaxine",{"v":704823,"d":"704,823.00"},{"v":0.704823,"d":"0.70"},"Direct funding","2020-09-02","https://vaxine.net/australian-government-funds-1m-for-development-of-covax-19-vaccine-mtpconnect/"]
["Australian government","Australia","Australia","Peter Doherty Institute/Monash University",{"v":1057234.5,"d":"1,057,234.50"},{"v":1.0572345,"d":"1.06"},"Direct funding","2021-04-01","https://www.monash.edu/pharm/about/news/news-listing/2021/monash-institute-of-pharmaceutical-sciences-receives-mrff-funding-for-covid-19-vaccine-phase-1-clinical-trial"]
["Australian government","Australia","Australia","University of Queensland",{"v":2361157.05,"d":"2,361,157.05"},{"v":2.3611570499999996,"d":"2.36"},"Direct funding","2020-03-22","https://www.health.gov.au/news/newsletters/mrff-newsletter-issue-3-march-2020"]
["Australian government","Australia","Australia","University of Queensland",{"v":1409646,"d":"1,409,646.00"},{"v":1.409646,"d":"1.41"},"Direct funding","2020-06-02","https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/66-million-for-coronavirus-related-research"]
["Australian government","Australia","Norway","CEPI",{"v":5286172.5,"d":"5,286,172.50"},{"v":5.2861725,"d":"5.29"},"Funding to intermediary","2020-05-05","https://www.pm.gov.au/media/coronavirus-global-response-international-pledging-event"]
["Austrian government","Austria","Norway","CEPI",{"v":2317018,"d":"2,317,018.00"},{"v":2.317018,"d":"2.32"},"Funding to intermediary","2020-07-02","https://cepi.net/news_cepi/austria-donates-e2-million-to-cepi-to-support-covid-19-vaccine-programmes/"]
["Avast Foundation","Czech Republic","Norway","CEPI",{"v":8000000,"d":"8,000,000.00"},{"v":8,"d":"8.00"},"Funding to intermediary","2020-04-29","https://www.avast.com/covid19"]
["Belgian government","Belgium","Norway","CEPI",{"v":5792545,"d":"5,792,545.00"},{"v":5.792545,"d":"5.79"},"Funding to intermediary","2020-04-03","https://www.flexmail.eu/r-2bd02b5b7f8213fa8c496d2be3592480#en"]
["BHP Foundation","Australia","Australia","University of Queensland",{"v":1409646,"d":"1,409,646.00"},{"v":1.409646,"d":"1.41"},"Direct funding","2020-04-29","https://www.bhp.com/sustainability/community/community-news/2020/04/bhp-foundation-commits-$3m-to-prevention-and-treatment-of-covid-19/"]
["Canadian Foundation for Innovation","Canada","Canada","VIDO-InterVac (Vaccine and Infectious Disease Organization)",{"v":8254972,"d":"8,254,972.00"},{"v":8.254972,"d":"8.25"},"Direct funding","2020-03-23","https://pm.gc.ca/en/news/news-releases/2020/03/23/canadas-plan-mobilize-science-fight-covid-19"]
["Canadian government","Canada","Canada","VIDO-InterVac (Vaccine and Infectious Disease Organization)",{"v":9005424,"d":"9,005,424.00"},{"v":9.005424,"d":"9.01"},"Direct funding","2020-03-23","https://pm.gc.ca/en/news/news-releases/2020/03/23/canadas-plan-mobilize-science-fight-covid-19"]
["Canadian government","Canada","Norway","CEPI",{"v":30018080,"d":"30,018,080.00"},{"v":30.01808,"d":"30.02"},"Funding to intermediary","2020-04-05","https://www.canada.ca/en/global-affairs/news/2020/04/backgrounder---canada-provides-funding-to-address-covid-19-pandemic.html"]
["Canadian government","Canada","Canada","University of Saskatchewan",{"v":750296.656436,"d":"750,296.66"},{"v":0.750296656436,"d":"0.75"},"Direct funding","2020-04-01","https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html"]
["Canadian government","Canada","Canada","University Laval",{"v":749968.7089120001,"d":"749,968.71"},{"v":0.7499687089120001,"d":"0.75"},"Direct funding","2020-04-01","https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html"]
["Canadian government","Canada","Canada","Québec University Hospital Centre",{"v":538558.12554,"d":"538,558.13"},{"v":0.53855812554,"d":"0.54"},"Direct funding","2020-04-01","https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html"]
["Canadian government","Canada","Canada","University of Alberta",{"v":562839,"d":"562,839.00"},{"v":0.562839,"d":"0.56"},"Direct funding","2020-04-01","https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html"]
["Canadian government","Canada","Canada","University of Manitoba",{"v":448115.901856,"d":"448,115.90"},{"v":0.44811590185600003,"d":"0.45"},"Direct funding","2020-04-01","https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html"]
["Canadian government","Canada","Canada","University of Western Ontario",{"v":749581.47568,"d":"749,581.48"},{"v":0.74958147568,"d":"0.75"},"Direct funding","2020-04-01","https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html"]
["Canadian government","Canada","Canada","VBI Vaccines Inc.",{"v":42025312,"d":"42,025,312.00"},{"v":42.025312,"d":"42.03"},"Direct funding","2020-08-05","https://www.vbivaccines.com/press-releases/canadian-govt-coronavirus-award/"]
["Canadian government","Canada","Canada","Medicago",{"v":129828196,"d":"129,828,196.00"},{"v":129.828196,"d":"129.83"},"Direct funding","2020-10-23","https://www.biospace.com/article/releases/prime-minister-announces-funding-to-advance-the-development-of-canadian-covid-19-vaccine-technologies/"]
["Canadian government","Canada","Norway","CEPI",{"v":15009040,"d":"15,009,040.00"},{"v":15.00904,"d":"15.01"},"Funding to intermediary","2020-06-27","https://www.canada.ca/en/global-affairs/news/2020/06/canada-announces-support-for-equitable-access-to-new-covid-19-medical-solutions.html"]
["Canadian government","Canada","Canada","VIDO-InterVac (Vaccine and Infectious Disease Organization)",{"v":17260396,"d":"17,260,396.00"},{"v":17.260396,"d":"17.26"},"Direct funding","2020-04-23","https://pm.gc.ca/en/news/news-releases/2020/04/23/prime-minister-announces-new-support-covid-19-medical-research-and"]
["Canadian government","Canada","Canada","Canadian Immunization Research Network",{"v":11481915.6,"d":"11,481,915.60"},{"v":11.481915599999999,"d":"11.48"},"Direct funding","2020-04-23","https://pm.gc.ca/en/news/news-releases/2020/04/23/prime-minister-announces-new-support-covid-19-medical-research-and"]
["Canadian government","Canada","Canada","Canadian National Research Council",{"v":11256780,"d":"11,256,780.00"},{"v":11.25678,"d":"11.26"},"Direct funding","2020-03-23","https://pm.gc.ca/en/news/news-releases/2020/03/23/canadas-plan-mobilize-science-fight-covid-19"]
["CEPI","CEPI","China","Sichuan Clover Biopharmaceuticals",{"v":66000000,"d":"66,000,000.00"},{"v":66,"d":"66.00"},"Secondary funding","2020-07-08","https://cepi.net/news_cepi/cepi-expands-partnership-with-clover-biopharmaceuticals-to-rapidly-advance-development-and-manufacture-of-covid-19-vaccine-candidate/"]
["CEPI","CEPI","Hong Kong","Hong Kong University",{"v":620000,"d":"620,000.00"},0.62,"Secondary funding","2020-03-18","https://cepi.net/news_cepi/cepi-partners-with-university-of-hong-kong-to-develop-covid-19-vaccine/"]
["CEPI","CEPI","India","Biological E Limited",{"v":5000000,"d":"5,000,000.00"},{"v":5,"d":"5.00"},"Secondary funding","2020-12-29","https://cepi.net/news_cepi/cepi-partners-with-biological-e-limited-to-advance-development-and-manufacture-of-covid-19-vaccine-candidate/"]
["CEPI","CEPI","China","Sichuan Clover Biopharmaceuticals",{"v":258500000,"d":"258,500,000.00"},{"v":258.5,"d":"258.50"},"Secondary funding","2020-11-03","https://www.pharmaceutical-business-review.com/news/cepi-clover-covid-19/"]
["CEPI","CEPI","South Korea","SK Biosciences",{"v":10000000,"d":"10,000,000.00"},{"v":10,"d":"10.00"},"Secondary funding","2020-12-09","https://cepi.net/news_cepi/cepi-and-sk-bioscience-to-develop-next-generation-covid-19-vaccine/"]
["CEPI","CEPI","United States of America","Inovio Pharmaceuticals",{"v":5300000,"d":"5,300,000.00"},{"v":5.3,"d":"5.30"},"Secondary funding","2020-05-04","https://cepi.net/wp-content/uploads/2020/12/Enabling-equitable-access-to-COVID19-vaccines-v3-22Feb-2021.pdf"]
["CEPI","CEPI","United States of America","Novavax",{"v":26500000,"d":"26,500,000.00"},{"v":26.5,"d":"26.50"},"Secondary funding","Unspecified","Personal communication"]
["CEPI","CEPI","United States of America","Novavax",{"v":4000000,"d":"4,000,000.00"},{"v":4,"d":"4.00"},"Secondary funding","2020-03-10","https://technical.ly/baltimore/2020/03/11/novavax-coronavirus-vaccine-candidate-manufactured-in-baltimore-emergent-biosolutions/"]
["CEPI","CEPI","Germany","CureVac",{"v":7000000,"d":"7,000,000.00"},{"v":7,"d":"7.00"},"Secondary funding","Unspecified","https://cepi.net/research_dev/our-portfolio/"]
["CEPI","CEPI","United States of America","Novavax",{"v":384000000,"d":"384,000,000.00"},{"v":384,"d":"384.00"},"Secondary funding","2020-05-11","https://cepi.net/news_cepi/cepi-extends-collaboration-with-novavax-to-advance-development-and-manufacture-of-covid-19-vaccine/"]
["CEPI","CEPI","Hong Kong","Hong Kong University",{"v":4800000,"d":"4,800,000.00"},{"v":4.8,"d":"4.80"},"Secondary funding","18/03/2021","https://cepi.net/news_cepi/cepi-and-university-of-hong-kong-expand-partnership-to-develop-intranasal-covid-19-vaccine-candidate/"]
["CEPI","CEPI","South Korea","SK Biosciences",{"v":14200000,"d":"14,200,000.00"},{"v":14.2,"d":"14.20"},"Secondary funding","2021-10-03","https://cepi.net/news_cepi/cepi-and-sk-bioscience-expand-partnership-to-develop-vaccine-against-covid-19-variants/"]
["CEPI","CEPI","United States of America","VBI Vaccines Inc.",{"v":33000000,"d":"33,000,000.00"},{"v":33,"d":"33.00"},"Secondary funding","2021-10-03","https://cepi.net/news_cepi/cepi-and-vbi-vaccines-collaborate-to-advance-vaccine-candidates-against-covid-19-variants/"]
["CEPI","CEPI","South Korea","SK Biosciences",{"v":53500000,"d":"53,500,000.00"},53.5,"Secondary funding","Unspecified","Personal communication"]
["CEPI","CEPI","South Korea","SK Biosciences",{"v":132400000,"d":"132,400,000.00"},132.4,"Secondary funding","2021-05-24","https://cepi.net/news_cepi/cepi-and-sk-bioscience-expand-partnership-to-advance-multiple-covid-19-variant-vaccines-and-scale-up-manufacturing/"]
["CEPI","CEPI","United States of America","Moderna",{"v":1000000,"d":"1,000,000.00"},{"v":1,"d":"1.00"},"Secondary funding","2020-01-23","https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-funding-award-cepi-accelerate-development"]
["CEPI","CEPI","France","Institut Pasteur",{"v":4900000,"d":"4,900,000.00"},{"v":4.9,"d":"4.90"},"Secondary funding","2020-03-19","https://cepi.net/news_cepi/cepi-collaborates-with-the-institut-pasteur-in-a-consortium-to-develop-covid-19-vaccine/"]
["CEPI","CEPI","Germany","CureVac",{"v":8300000,"d":"8,300,000.00"},{"v":8.3,"d":"8.30"},"Secondary funding","2020-01-31","https://cepi.net/news_cepi/curevac-and-cepi-extend-their-cooperation-to-develop-a-vaccine-against-coronavirus-ncov-2019/"]
["CEPI","CEPI","United States of America","Inovio Pharmaceuticals",{"v":9000000,"d":"9,000,000.00"},{"v":9,"d":"9.00"},"Secondary funding","2020-01-23","https://www.prnewswire.com/news-releases/inovio-selected-by-cepi-to-develop-vaccine-against-new-coronavirus-300992131.html"]
["CEPI","CEPI","Australia","University of Queensland",{"v":5700000,"d":"5,700,000.00"},{"v":5.7,"d":"5.70"},"Secondary funding","2020-01-16","https://www.uq.edu.au/news/article/2019/01/partnership-supercharge-vaccine-production\n\nhttps://cepi.net/COVAX/"]
["CEPI","CEPI","United States of America","Inovio Pharmaceuticals",{"v":6900000,"d":"6,900,000.00"},{"v":6.9,"d":"6.90"},"Secondary funding","2020-04-16","https://cepi.net/news_cepi/ivi-inovio-and-knih-to-partner-with-cepi-in-a-phase-i-ii-clinical-trial-of-inovios-covid-19-dna-vaccine-in-south-korea/\nhttp://ir.inovio.com/news-releases/news-releases-details/2020/IVI-INOVIO-and-KNIH-to-Partner-with-CEPI-in-Phase-12-Clinical-Trial-of-INOVIOs-COVID-19-DNA-Vaccine-in-South-Korea/default.aspx"]
["CEPI","CEPI","China","Sichuan Clover Biopharmaceuticals",{"v":3500000,"d":"3,500,000.00"},{"v":3.5,"d":"3.50"},"Secondary funding","2020-04-27","https://cepi.net/news_cepi/cepi-announces-covid-19-vaccine-development-partnership-with-clover-biopharmaceuticals-australian-subsidiary/"]
["CEPI","CEPI","United States of America","Inovio Pharmaceuticals",{"v":1300000,"d":"1,300,000.00"},{"v":1.3,"d":"1.30"},"Secondary funding","2020-05-04","https://www.phillymag.com/healthcare-news/2020/05/02/inovio-pharmaceuticals-covid-19-vaccine/\nhttp://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-Expands-Manufacturing-of-COVID-19-DNA-Vaccine-INO-4800-With-New-Funding-from-CEPI/default.aspx"]
["CEPI","CEPI","United Kingdom","Oxford/AstraZeneca",{"v":1100000,"d":"1,100,000.00"},{"v":1.1,"d":"1.10"},"Secondary funding","2020-04-23","https://cepi.net/research_dev/our-portfolio/"]
["China Evergrande Group","China","China, United States of America","Zhong Nanshan Team and Harvard University: Sino-US\nCOVID-19 Scientific Research Expert Team",{"v":115000000,"d":"115,000,000.00"},{"v":115,"d":"115.00"},"Direct funding","2020-02-04","https://doc.irasia.com/listco/hk/evergrande/annual/2020/esr.pdff\nhttps://www.universityworldnews.com/post.php?story=20210113092455389"]
["China Evergrande Group","China","China","Chinese Academy of Medical Sciences",{"v":14000000,"d":"14,000,000.00"},{"v":14,"d":"14.00"},"Direct funding","2020-02-08","https://doc.irasia.com/listco/hk/evergrande/annual/2020/esr.pdff\nhttps://www.universityworldnews.com/post.php?story=20210113092455389"]
["Chinese Academy of Medical Sciences","China","United Kingdom","Oxford/AstraZeneca",{"v":88135.80163694,"d":"88,135.80"},{"v":0.08813580163694,"d":"0.09"},"Direct funding","2020-03-01","https://www.whatdotheyknow.com/request/701825/response/1678268/attach/2/FOI%2020201025%2003%20Ltr%20Funding%20of%20Covid%20vaccine.pdf?cookie_passthrough=1"]
["CNPG","China","China","Sinopharm",{"v":144961999.99999997,"d":"144,962,000.00"},{"v":144.96199999999996,"d":"144.96"},"Direct funding","2020-04-14","http://www.xinhuanet.com/english/2020-04/14/c_138974915.htm"]
["COVID-19 Solidarity Response Fund","Switzerland","Norway","CEPI",{"v":10000000,"d":"10,000,000.00"},{"v":10,"d":"10.00"},"Funding to intermediary","2020-04-10","https://unfoundation.org/media/covid-19-solidarity-response-fund-distributes-10m-for-vaccine-development/"]
["Dolly Parton COVID-19 Research Fund ","United States of America","United States of America","Moderna",{"v":1000000,"d":"1,000,000.00"},{"v":1,"d":"1.00"},"Direct funding","2020-11-18","https://www.nytimes.com/2020/11/18/world/dolly-parton-donated-1-million-to-help-develop-a-coronavirus-vaccine.html (accessed Jan 18, 2021)."]
["Dutch government","Netherlands","Norway","CEPI",{"v":57925450,"d":"57,925,450.00"},{"v":57.92545,"d":"57.93"},"Funding to intermediary","2020-04-16","https://cepi.net/news_cepi/netherlands-and-switzerland-join-the-search-for-covid-19-vaccines/"]
["EIC","European Union","Ireland","Remedy Biologics Limited",{"v":2896272.5,"d":"2,896,272.50"},{"v":2.8962725,"d":"2.90"},"Direct funding","2020-06-08","https://cordis.europa.eu/project/id/961112"]
["EIC","European Union","France","Osivax",{"v":2851231.987098,"d":"2,851,231.99"},{"v":2.851231987098,"d":"2.85"},"Direct funding","2020-06-08","https://ec.europa.eu/research/eic/pdf/ec_rtd_cv-accelerator-projects.pdf"]
["Ethiopian government","Ethiopia","Norway","CEPI",{"v":300000,"d":"300,000.00"},{"v":0.3,"d":"0.30"},"Funding to intermediary","2020-02-10","https://cepi.net/news_cepi/ethiopia-funds-coalition-for-epidemic-preparedness-innovations-to-combat-spread-of-epidemics/"]
["European Commission","European Union","European Union","OPENCORONA project",{"v":3475527,"d":"3,475,527.00"},{"v":3.475527,"d":"3.48"},"Direct funding","2020-04-01","https://cordis.europa.eu/project/id/101003666"]
["European Commission","European Union","Norway","CEPI",{"v":115850900,"d":"115,850,900.00"},{"v":115.8509,"d":"115.85"},"Funding to intermediary","2020-05-04","https://ec.europa.eu/commission/presscorner/detail/en/ip_20_797"]
["European Commission","European Union","European Union","Prevent-nCoV Project",{"v":3160806.44506,"d":"3,160,806.45"},{"v":3.16080644506,"d":"3.16"},"Direct funding","2020-03-06","https://cordis.europa.eu/project/id/101003608"]
["European Investment Bank","European Union","Germany","Pfizer/BioNTech",{"v":115850900,"d":"115,850,900.00"},{"v":115.8509,"d":"115.85"},"Direct funding","2020-06-11","https://www.globenewswire.com/news-release/2020/06/11/2046651/0/en/Investment-Plan-for-Europe-European-Investment-Bank-to-provide-BioNTech-with-up-to-100-million-in-debt-financing-for-COVID-19-vaccine-development-and-manufacturing.html"]
["European Investment Bank","European Union","Germany","CureVac",{"v":86888175,"d":"86,888,175.00"},{"v":86.888175,"d":"86.89"},"Direct funding","2020-07-06","https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1238"]
["Finnish government ","Finland","Norway","CEPI",{"v":4634036,"d":"4,634,036.00"},{"v":4.634036,"d":"4.63"},"Funding to intermediary","2020-04-16","https://valtioneuvosto.fi/en/article/-/asset_publisher/1271139/suomi-sitoutuu-kansainvaliseen-rokotetutkimukseen-koronavirusrokotteen-kehittamiseksi"]
["Finnish government ","Finland","South Korea","IVI",{"v":1158509,"d":"1,158,509.00"},{"v":1.158509,"d":"1.16"},"Funding to intermediary","2020-04-16","https://valtioneuvosto.fi/en/article/-/asset_publisher/1271139/suomi-sitoutuu-kansainvaliseen-rokotetutkimukseen-koronavirusrokotteen-kehittamiseksi"]
["French government","France","France","OSE Immunotherapeutics",{"v":231701.8,"d":"231,701.80"},{"v":0.23170179999999999,"d":"0.23"},"Direct funding","2020-07-16","https://www.globenewswire.com/news-release/2020/07/16/2063020/0/en/OSE-Immunotherapeutics-Receives-200-000-from-Nantes-Metropole-to-Develop-CoVepiT-its-COVID-19-Prophylactic-Vaccine-Program.html"]
["French government","France","France","Osivax",{"v":17493485.9,"d":"17,493,485.90"},{"v":17.4934859,"d":"17.49"},"Direct funding","2020-07-08","http://www.osivax.com/osivax-receives-over-eur-30m-in-public-funding-to-support-development-of-universal-coronavirus--influenza-vaccines.html"]
["Fundación Jesús Serra","Spain","Spain","Spanish CSIC",{"v":405478.15,"d":"405,478.15"},{"v":0.40547815000000004,"d":"0.41"},"Direct funding","2020-04-05","https://www.csic.es/es/actualidad-del-csic/el-csic-recibe-350000-euros-del-grupo-catalana-occidente-para-contribuir-lograr"]
["Gates Foundation","United States of America","United States of America","Inovio Pharmaceuticals",{"v":5000000,"d":"5,000,000.00"},{"v":5,"d":"5.00"},"Direct funding","2020-03-12","http://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-Receives-New-5-Million-Grant-to-Accelerate-Scale-Up-of-Smart-Delivery-Device-for-Its-COVID-19-Vaccine/default.aspx"]
["Gates Foundation","United States of America","South Korea","IVI",{"v":1500000,"d":"1,500,000.00"},{"v":1.5,"d":"1.50"},"Funding to intermediary","2020-09-09","https://www.ivi.int/ivi-to-ready-clinical-trial-sites-for-covid-19-vaccine-efficacy-trials-in-4-countries/"]
["Gates Foundation","United States of America","United States of America","Novavax",{"v":15000000,"d":"15,000,000.00"},{"v":15,"d":"15.00"},"Direct funding","2020-08-17","http://ir.novavax.com/news-releases/news-release-details/novavax-initiates-efficacy-trial-covid-19-vaccine-south-africa"]
["Gates Foundation","United States of America","India","Biological E Limited",{"v":4019427,"d":"4,019,427.00"},{"v":4.019427,"d":"4.02"},"Direct funding","2020-04-01","https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2020/04/INV-016076"]
["Gates Foundation","United States of America","Norway","CEPI",{"v":20000000,"d":"20,000,000.00"},{"v":20,"d":"20.00"},"Funding to intermediary","2020-11-12","https://www.reuters.com/article/health-coronavirus-gates-funding-int-idUSKBN27S0RX"]
["Gates Foundation","United States of America","Australia","Melbourne Children’s Trials Centre",{"v":7048230,"d":"7,048,230.00"},{"v":7.04823,"d":"7.05"},"Direct funding","2020-05-05","https://www.mcri.edu.au/news/10m-grant-enables-mcris-bcg-vaccine-trial-expand-internationally"]
["Gates Foundation","United States of America","South Korea","SK Biosciences",{"v":3600000,"d":"3,600,000.00"},{"v":3.6,"d":"3.60"},"Direct funding","2020-05-18","http://www.koreabiomed.com/news/articleView.html?idxno=8274"]
["German government","Germany","Norway","CEPI",{"v":139021080,"d":"139,021,080.00"},139.02,"Funding to intermediary","2021-02-25","https://cepi.net/news_cepi/in-the-fight-against-novel-covid-19-variants-norway-and-germany-provide-vital-additional-funds-to-cepi/"]
["German government","Germany","Germany","Pfizer/BioNTech",{"v":434440875,"d":"434,440,875.00"},{"v":434.440875,"d":"434.44"},"Direct funding","2020-09-15","https://investors.biontech.de/news-releases/news-release-details/biontech-receive-eu375m-funding-german-federal-ministry/"]
["German government","Germany","Germany","Curevac",{"v":291944268,"d":"291,944,268.00"},{"v":291.944268,"d":"291.94"},"Direct funding","2020-09-15","https://www.reuters.com/article/us-health-coronavirus-germany-vaccine/germany-grants-biontech-curevac-745-million-to-speed-up-covid-19-vaccine-work-idUSKBN2661JB"]
["German government","Germany","Germany","IDT-Biologika",{"v":132070026,"d":"132,070,026.00"},{"v":132.070026,"d":"132.07"},"Direct funding","2020-10-08","https://idt-biologika.com/idt-biologika-receives-official-notification-of-funding-from-the-federal-government"]
["German government","Germany","Norway","CEPI",{"v":162191260,"d":"162,191,260.00"},{"v":162.19126,"d":"162.19"},"Funding to intermediary","2020-03-12","https://cepi.net/news_cepi/cepi-gets-e140-million-funding-boost-from-germany-while-expanding-coronavirus-vaccine-search/"]
["Glencore","Australia","Australia","University of Queensland",{"v":510996.675,"d":"510,996.68"},{"v":0.510996675,"d":"0.51"},"Direct funding","2020-07-14","https://www.glencore.com.au/media-and-insights/news/glencore-provides-725-000-to-university-of-queensland-covid-19-vaccine-development"]
["Government of Quebec","Canada","Canada","Medicago",{"v":5253164,"d":"5,253,164.00"},{"v":5.253164,"d":"5.25"},"Direct funding","2020-03-21","https://www.medicago.com/en/newsroom/government-of-quebec-providing-7-million-towards-medicagou2019s-covid-19-vaccine-development/"]
["Greek government","Greece","Norway","CEPI",{"v":1737763.5,"d":"1,737,763.50"},{"v":1.7377635,"d":"1.74"},"Funding to intermediary","2020-06-09","https://cepi.net/news_cepi/greece-announces-1-6-million-funding-to-cepi-to-support-covid-19-vaccine-development/"]
["Hong Kong government","Hong Kong","Hong Kong","Hong Kong University",{"v":412899.0774613333,"d":"412,899.08"},{"v":0.4128990774613333,"d":"0.41"},"Direct funding","2020-04-27","https://rfs2.fhb.gov.hk/images/HMRF/COVID_19_List.pdf"]
["Hong Kong government","Hong Kong","Hong Kong","Hong Kong University",{"v":2622020.6857706667,"d":"2,622,020.69"},{"v":2.6220206857706665,"d":"2.62"},"Direct funding","2020-04-27","https://rfs2.fhb.gov.hk/images/HMRF/COVID_19_List.pdf"]
["Hong Kong government","Hong Kong","Hong Kong","Hong Kong University",{"v":386768,"d":"386,768.00"},{"v":0.386768,"d":"0.39"},"Direct funding","2020-04-27","https://rfs2.fhb.gov.hk/images/HMRF/COVID_19_List.pdf"]
["Iceland governmen","Iceland","Norway","CEPI",{"v":1950000,"d":"1,950,000.00"},1.95,"Funding to intermediary","2020-06-12","https://www.stjornarradid.is/default.aspx?pageid=e5cf150d-33a7-11e6-80c7-005056bc217f&newsid=cec9bbe9-a681-11ea-8114-005056bc8c60"]
["Indian govt/ BIRAC","India","India","Gennova Biopharmaceuticals Ltd",{"v":13486999.999999998,"d":"13,487,000.00"},{"v":13.486999999999998,"d":"13.49"},"Direct funding","2021-04-21","https://health.economictimes.indiatimes.com/news/finance/gennova-to-get-rs-100-crore-from-govt-for-covid-19-vaccine/82023451 ; https://pib.gov.in/PressReleasePage.aspx?PRID=1711304"]
["Indonesian government","Indonesia","Indonesia","Eijkman Institute of Microbiology",{"v":344166.6666666666,"d":"344,166.67"},{"v":0.3441666666666666,"d":"0.34"},"Direct funding","2020-05-05","https://www.thejakartapost.com/news/2020/05/05/indonesia-targets-local-covid-19-strain-in-eijkman-led-2022-vaccine-initiative.html"]
["Jack Ma Foundation","China","United States of America","Columbia University",{"v":2150000,"d":"2,150,000.00"},2.15,"Direct funding","2020-02-21","https://www.jackmafoundation.org.cn/blog/hands-with-columbia-university-for-covid-19/"]
["Jack Ma Foundation","China","China","Guangdong Zhong Nanshan Medical Foundation, Guangzhou Institute of Respiratory Health",{"v":860000,"d":"860,000.00"},0.86,"Direct funding","2020-02-13","https://www.jackmafoundation.org.cn/program/covid-19/fund"]
["Jack Ma Foundation","China","China","Chinese Academy of Engineering",{"v":2850000,"d":"2,850,000.00"},2.85,"Direct funding","2020-02-07","https://www.jackmafoundation.org.cn/program/covid-19/fund"]
["Jack Ma Foundation","China","China","Chinese Academy of Medical Sciences",{"v":2850000,"d":"2,850,000.00"},2.85,"Direct funding","2020-02-11","https://www.jackmafoundation.org.cn/program/covid-19/fund"]
["Jack Ma Foundation","China","Australia","Peter Doherty Institute/Monash University",{"v":2150000,"d":"2,150,000.00"},2.15,"Direct funding","2020-03-02","https://www.jackmafoundation.org.cn/program/covid-19/fund"]
["Japanese government","Japan","Japan","Japanese National Institute of Infectious Diseases",{"v":936741.6666666667,"d":"936,741.67"},{"v":0.9367416666666667,"d":"0.94"},"Direct funding","2020-02-13","https://www.amed.go.jp/content/000058931.pdf"]
["Japanese government","Japan","Japan","University of Tokyo",{"v":1405112.5000000002,"d":"1,405,112.50"},{"v":1.4051125000000002,"d":"1.41"},"Direct funding","2020-02-13","https://www.amed.go.jp/content/000058931.pdf"]
["KfW","Germany","Germany","Curevac",{"v":347552700,"d":"347,552,700.00"},{"v":347.5527,"d":"347.55"},"Direct funding","2020-08-06","https://www.kfw.de/KfW-Group/Newsroom/Latest-News/News-Details_600640.html"]
["Love, Tito’s","United States of America","United States of America","Baylor College of Medicine",{"v":1000000,"d":"1,000,000.00"},{"v":1,"d":"1.00"},"Direct funding","2020-05-14","https://www.bcm.edu/news/infectious-diseases/baylor-covid-19-vaccine-funding-titos-vodka"]
["Minderoo Foundation","Australia","Australia","Telethon Kids Institute",{"v":1057234.5,"d":"1,057,234.50"},{"v":1.0572345,"d":"1.06"},"Direct funding","2020-04-14","https://www.telethonkids.org.au/news--events/news-and-events-nav/2020/april/minderoo-foundation-funds-vaccine-trial-covid-19/"]
["Ministry of Economy and Innovation of Quebec","Canada","Canada","Medicago",{"v":375226,"d":"375,226.00"},{"v":0.375226,"d":"0.38"},"Direct funding","2020-05-05","https://www.medicago.com/en/media-room/collaborative-project-of-more-than-1-2-million-using-artificial-intelligence-to-optimize-the-production-of-vaccines-announced-by-cqdm-and-medicago-r-d/"]
["Ministry of Health and Welfare","Taiwan","United States of America","COVAXX",{"v":15000000,"d":"15,000,000.00"},{"v":15,"d":"15.00"},"Direct funding","2020-09-28","https://www.prnewswire.com/news-releases/covaxx-initiates-phase-1-clinical-trial-of-covid-19-vaccine-ub-612-in-taiwan-301138711.html"]
["Multiple Nigerian funders","Nigeria","Nigeria","Nigerian COVID-19 Research Group",{"v":18720,"d":"18,720.00"},{"v":0.01872,"d":"0.02"},"Direct funding","2020-06-19","https://guardian.ng/news/nigerian-universities-scientists-discover-vaccine-for-covid-19/"]
["Nestlé","Switzerland","Norway","CEPI",{"v":1007822.1349717611,"d":"1,007,822.13"},{"v":1.007822134971761,"d":"1.01"},"Funding to intermediary","2020-05-20","https://twitter.com/CEPIvaccines/status/1263023497888124928"]
["New Zealand government","New Zealand","Norway","CEPI",{"v":9909825,"d":"9,909,825.00"},{"v":9.909825,"d":"9.91"},"Funding to intermediary","2020-05-26","https://www.beehive.govt.nz/release/new-zealand-joins-global-search-covid-19-vaccine"]
["Newcrest Mining","Australia","Australia","University of Queensland",{"v":704823,"d":"704,823.00"},{"v":0.704823,"d":"0.70"},"Direct funding","2020-05-08","https://www.newcrest.com/sites/default/files/2020-05/200508_Newcrest%20partners%20with%20University%20of%20Queensland%20in%20support%20of%20COVID19%20vaccine%20research%20-%20Media%20Release.pdf"]
["Norwegian government","Norway","Norway","CEPI",{"v":21545000,"d":"21,545,000.00"},21.55,"Funding to intermediary","2021-02-25","https://cepi.net/news_cepi/in-the-fight-against-novel-covid-19-variants-norway-and-germany-provide-vital-additional-funds-to-cepi/"]
["Norwegian government","Norway","Norway","CEPI",{"v":236995000,"d":"236,995,000.00"},{"v":236.995,"d":"237.00"},"Funding to intermediary","2020-04-01","https://cepi.net/news_cepi/norway-intensifies-covid-19-fight-with-nok2-2-billion-donation-to-cepi/"]
["Norwegian government","Norway","Norway","CEPI",{"v":3878100,"d":"3,878,100.00"},{"v":3.8781,"d":"3.88"},"Funding to intermediary","2020-02-17","https://cepi.net/news_cepi/cepi-gets-e140-million-funding-boost-from-germany-while-expanding-coronavirus-vaccine-search/"]
["Oxford Biomedical Research Centre","United Kingdom","United Kingdom","Oxford/AstraZeneca",{"v":388941.63823200006,"d":"388,941.64"},{"v":0.38894163823200006,"d":"0.39"},"Direct funding","2020-04-01","https://www.whatdotheyknow.com/request/breakdown_of_funding_for_the_cha"]
["Oxford Biomedical Research Centre","United Kingdom","United Kingdom","Oxford/AstraZeneca",{"v":836201.487379,"d":"836,201.49"},{"v":0.836201487379,"d":"0.84"},"Direct funding","2020-04-01","https://www.whatdotheyknow.com/request/breakdown_of_funding_for_the_cha"]
["Paul Ramsay Foundation","Australia","Australia","Peter Doherty Institute/Monash University",{"v":1409646,"d":"1,409,646.00"},{"v":1.409646,"d":"1.41"},"Direct funding","2020-03-22","https://www.doherty.edu.au/news-events/news/paul-ramsay-foundation-commits-4m-towards-the-doherty-institutes-covid-19-r"]
["Paul Ramsay Foundation","Australia","Australia","University of Queensland",{"v":2466880.5,"d":"2,466,880.50"},{"v":2.4668805,"d":"2.47"},"Direct funding","2020-03-22","http://statements.qld.gov.au/Statement/2020/3/22/state-and-federal-govts-fund-development-of-covid19-vaccine"]
["Queensland state government","Australia","Australia","University of Queensland",{"v":7048230,"d":"7,048,230.00"},{"v":7.04823,"d":"7.05"},"Direct funding","2020-03-22","http://statements.qld.gov.au/Statement/2020/3/22/state-and-federal-govts-fund-development-of-covid19-vaccine"]
["RACQ","Australia","Australia","University of Queensland",70482.3,0.0704823,"Direct funding","2020-04-15","https://www.racq.com.au/Live/Articles/CN-150420-RACQ-drives-100k-donation-to-UQ-COVID19-vaccine"]
["Royal Children’s Hospital Foundation","Australia","Australia","Melbourne Children’s Trials Centre",{"v":281929.2,"d":"281,929.20"},{"v":0.2819292,"d":"0.28"},"Direct funding","2020-05-05","https://www.mcri.edu.au/news/10m-grant-enables-mcris-bcg-vaccine-trial-expand-internationally"]
["Russian Development Investment Fund","Russia","Russia","Gamaleya Institute",{"v":295000000,"d":"295,000,000.00"},295,"Direct funding","2021-02-09","https://www.vedomosti.ru/business/news/2021/09/02/884862-rfpi-nazval-obem-investitsii-v-sputnik"]
["Russian Ministry of Health","Russia","Russia","Gamaleya Institute",{"v":399500000,"d":"399,500,000.00"},399.5,"Direct funding"]
["Sarah and Lachlan Murdoch","Australia","Australia","Melbourne Children’s Trials Centre",{"v":493376.1,"d":"493,376.10"},{"v":0.4933761,"d":"0.49"},"Direct funding","2020-05-05","https://www.mcri.edu.au/news/10m-grant-enables-mcris-bcg-vaccine-trial-expand-internationally"]
["Saudi Arabian government","Saudi Arabia","Norway","CEPI",{"v":150000000,"d":"150,000,000.00"},{"v":150,"d":"150.00"},"Funding to intermediary","2020-04-21","https://cepi.net/news_cepi/saudi-arabia-pledges-us150-million-to-cepi-covid-19-response/"]
["Serbian Government","Serbia","Norway","CEPI",{"v":115850.9,"d":"115,850.90"},{"v":0.11585089999999999,"d":"0.12"},"Funding to intermediary","2020-06-28","https://twitter.com/GlblCtznImpact/status/1276896581787234305"]
["Sino Biopharmaceuticals","Hong Kong","China","SinoVac",{"v":500000000,"d":"500,000,000.00"},{"v":500,"d":"500.00"},"Direct funding","2020-12-06","https://www.aa.com.tr/en/asia-pacific/china-s-sinovac-gets-500m-funding-for-covid-19-vaccine/2067846 ; https://www.crunchbase.com/organization/sinovac-life-sciences/company_financials"]
["SMBC Group","Japan","Norway","CEPI",{"v":1158509.0000000002,"d":"1,158,509.00"},{"v":1.1585090000000002,"d":"1.16"},"Funding to intermediary","2020-06-30","https://www.smfg.co.jp/news_e/e110152_01.html"]
["South Australian state government","Australia","Australia","South Australian Health and Medical Rresearch Institute",{"v":140964.6,"d":"140,964.60"},{"v":0.1409646,"d":"0.14"},"Direct funding","2020-05-05","https://www.mcri.edu.au/news/10m-grant-enables-mcris-bcg-vaccine-trial-expand-internationally"]
["Spanish government","Spain","Norway","CEPI",{"v":86888175,"d":"86,888,175.00"},{"v":86.888175,"d":"86.89"},"Funding to intermediary","2020-05-05","https://twitter.com/sanchezcastejon/status/1257318454995988483"]
["Swiss government. ","Switzerland","Norway","CEPI",{"v":10805419.999999998,"d":"10,805,420.00"},{"v":10.805419999999998,"d":"10.81"},"Funding to intermediary","2020-04-16","https://cepi.net/news_cepi/netherlands-and-switzerland-join-the-search-for-covid-19-vaccines/"]
["Taiwanese government","Taiwan","Taiwan","Medigen",{"v":16400000,"d":"16,400,000.00"},{"v":16.4,"d":"16.40"},"Direct funding","2020-10-13","file:///C:/Users/alonsoru/Zotero/storage/8A4BWSAB/medigens-covid-19-vaccine-combined-with-dynavaxs-cpg-1018-adjuvant-receives-taiwan-government-s.html"]
["Temasek","Singapore","Germany","Pfizer/BioNTech",{"v":250000000,"d":"250,000,000.00"},{"v":250,"d":"250.00"},"Direct funding","2020-06-29","https://www.reuters.com/article/us-biontech-placement/temasek-led-investor-group-in-250-million-vaccine-bet-on-germanys-biontech-idUSKBN2400PS"]
["Tencent Charity Foundation","China","China","Tsinghua University Education Foundation",{"v":724810,"d":"724,810.00"},{"v":0.72481,"d":"0.72"},"Direct funding","2020-02-01","https://gongyi.qq.com/a/20200321/000094.htm"]
["The a2 Milk Company","New Zealand","Australia","University of Queensland",{"v":330327.5,"d":"330,327.50"},{"v":0.3303275,"d":"0.33"},"Direct funding","2020-02-12","https://thea2milkcompany.com/wp-content/uploads/The-a2-Milk-Company-supporting-independent-research-for-a-Coronavirus-vaccine_Feb-2020.pdf"]
["The a2 Milk Company","New Zealand","Australia","Peter Doherty Institute/Monash University",{"v":330327.5,"d":"330,327.50"},{"v":0.3303275,"d":"0.33"},"Direct funding","2020-02-12","https://thea2milkcompany.com/wp-content/uploads/The-a2-Milk-Company-supporting-independent-research-for-a-Coronavirus-vaccine_Feb-2020.pdf"]
["The Lott","Australia","Australia","University of Queensland",{"v":704823,"d":"704,823.00"},{"v":0.704823,"d":"0.70"},"Direct funding","2020-04-03","https://www.thelott.com/real-winners/the-lott/golden-casket-donates-to-covid-19-vaccine-research"]
["UK government","United Kingdom","United Kingdom","Imperial College London",{"v":2199954.7,"d":"2,199,954.70"},{"v":2.1999547,"d":"2.20"},"Direct funding","2020-04-17","https://www.ukri.org/news/covid-19-research-boosted-by-new-projects/"]
["UK government","United Kingdom","United Kingdom","Oxford/AstraZeneca",{"v":2847000.2,"d":"2,847,000.20"},{"v":2.8470002,"d":"2.85"},"Direct funding","2020-03-23","https://mrc.ukri.org/news/browse/covid-19-vaccine-therapy-research-boosted-by-six-new-projects-in-rapid-response/\nhttps://www.gov.uk/government/news/vaccine-trials-among-recipients-of-20-million-coronavirus-research-investment"]
["UK government","United Kingdom","United Kingdom","Oxford/AstraZeneca",{"v":517636.4,"d":"517,636.40"},{"v":0.5176364,"d":"0.52"},"Direct funding","2020-03-23","https://mrc.ukri.org/news/browse/covid-19-vaccine-therapy-research-boosted-by-six-new-projects-in-rapid-response/\nhttps://www.gov.uk/government/news/vaccine-trials-among-recipients-of-20-million-coronavirus-research-investment"]
["UK government","United Kingdom","United Kingdom","Scancell",{"v":2588182,"d":"2,588,182.00"},{"v":2.588182,"d":"2.59"},"Direct funding","2020-08-27","https://www.scancell.co.uk/Data/Sites/1/media/publications/rns/covid-19-innovate-uk-final-27.08.20.pdf"]
["UK government","United Kingdom","United Kingdom","Vaccitech",{"v":2976409.3000000003,"d":"2,976,409.30"},{"v":2.9764093000000003,"d":"2.98"},"Direct funding","2020-08-27","https://www.vaccitech.co.uk/vaccitech-government-grant-covid19/"]
["UK government","United Kingdom","Norway","CEPI",{"v":25881820.000000004,"d":"25,881,820.00"},{"v":25.881820000000005,"d":"25.88"},"Funding to intermediary","2020-02-03","https://www.gov.uk/government/news/20m-announced-to-fund-vaccines-for-coronavirus-and-other-infectious-diseases"]
["UK government","United Kingdom","Norway","CEPI",{"v":25881820.000000004,"d":"25,881,820.00"},{"v":25.881820000000005,"d":"25.88"},"Funding to intermediary","2020-03-06","https://www.gov.uk/government/news/pm-announces-new-funding-in-fight-against-spread-of-coronavirus"]
["UK government","United Kingdom","Norway","CEPI",{"v":271759110,"d":"271,759,110.00"},{"v":271.75911,"d":"271.76"},"Funding to intermediary","2020-03-26","https://www.gov.uk/government/news/pm-announces-record-funding-to-find-a-coronavirus-vaccine"]
["UK government","United Kingdom","United Kingdom","Imperial College London",{"v":29117047.500000004,"d":"29,117,047.50"},{"v":29.117047500000005,"d":"29.12"},"Direct funding","2020-04-22","https://www.imperial.ac.uk/news/197017/imperial-covid19-vaccine-team-secures-225/"]
["UK government","United Kingdom","United Kingdom","Imperial College London",{"v":23940683.500000004,"d":"23,940,683.50"},{"v":23.940683500000002,"d":"23.94"},"Direct funding","2020-05-17","https://www.imperial.ac.uk/news/197573/covid-19-vaccine-secures-government-investment/"]
["UK government","United Kingdom","United Kingdom","Oxford/AstraZeneca",{"v":25881820.000000004,"d":"25,881,820.00"},{"v":25.881820000000005,"d":"25.88"},"Direct funding","2020-04-22","https://www.imperial.ac.uk/news/197017/imperial-covid19-vaccine-team-secures-225/"]
["UK government","United Kingdom","United Kingdom","Oxford/AstraZeneca",{"v":84762960.5,"d":"84,762,960.50"},{"v":84.7629605,"d":"84.76"},"Direct funding","2020-05-17","https://www.imperial.ac.uk/news/197573/covid-19-vaccine-secures-government-investment/"]
["US DOD","United States of America","United States of America","Inovio Pharmaceuticals",{"v":71000000,"d":"71,000,000.00"},{"v":71,"d":"71.00"},"Direct funding","2020-06-23","http://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-Receives-71-Million-Contract-From-US-Department-of-Defense-To-Scale-Up-Manufacture-of-CELLECTRA-3PSP-Smart-Device-and-Procurement-of-CELLECTRA-2000-for-COVID-19-DNA-Vaccine/default.aspx"]
["US government","United States of America","United States of America","Colorado State University",{"v":699994,"d":"699,994.00"},{"v":0.699994,"d":"0.70"},"Direct funding","2020-06-25","https://www.medicalcountermeasures.gov/newsroom/2020/csu/"]
["US government","United States of America","United States of America","Verndari",{"v":698215,"d":"698,215.00"},{"v":0.698215,"d":"0.70"},"Direct funding","2020-07-24","https://www.medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx"]
["US government","United States of America","United States of America","Vaxess Technologies",{"v":749000,"d":"749,000.00"},{"v":0.749,"d":"0.75"},"Direct funding","2020-08-10","https://www.medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx"]
["US government","United States of America","United States of America","University of Connecticut",{"v":432990,"d":"432,990.00"},{"v":0.43299,"d":"0.43"},"Direct funding","2020-08-18","https://www.medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx"]
["US government","United States of America","United States of America","Esperovax, Inc",{"v":606780,"d":"606,780.00"},{"v":0.60678,"d":"0.61"},"Direct funding","2020-07-28","https://www.medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx"]
["US government","United States of America","Belgium","Janssen",{"v":456237081,"d":"456,237,081.00"},{"v":456.237081,"d":"456.24"},"Direct funding","2020-03-30","https://www.medicalcountermeasures.gov/newsroom/2020/janssen-vaccine-covid-19/"]
["US government","United States of America","United States of America","Moderna",{"v":53000000,"d":"53,000,000.00"},{"v":53,"d":"53.00"},"Direct funding","2020-05-24","https://www.medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx"]
["US government","United States of America","United States of America","Moderna",{"v":472000000,"d":"472,000,000.00"},{"v":472,"d":"472.00"},"Direct funding","2020-07-27","https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-expansion-barda-agreement-support-larger-phase"]
["US government","United States of America","France/United Kingdom","Sanofi Pasteur/GSK",{"v":30775336,"d":"30,775,336.00"},{"v":30.775336,"d":"30.78"},"Direct funding","2020-02-18","https://www.sanofi.com/en/media-room/press-releases/2020/2020-02-18-16-00-00"]
["US government","United States of America","United States of America","Moderna",{"v":430298520,"d":"430,298,520.00"},{"v":430.29852,"d":"430.30"},"Direct funding","2020-03-30","https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-award-us-government-agency-barda-483-million"]
["US government","United States of America","United States of America","Merck",{"v":38033570,"d":"38,033,570.00"},{"v":38.03357,"d":"38.03"},"Direct funding","2020-05-26","https://www.medicalcountermeasures.gov/newsroom/2020/merck-iavi/"]
["US government","United States of America","United States of America","Adaptive Phage Therapeutics (APT)",{"v":9800000,"d":"9,800,000.00"},{"v":9.8,"d":"9.80"},"Direct funding","2020-08-20","https://www.businesswire.com/news/home/20200820005593/en/Adaptive-Phage-Therapeutics-Receives-Department-Defense-Award"]
["US government","United States of America","United States of America","Novavax",{"v":60000000,"d":"60,000,000.00"},{"v":60,"d":"60.00"},"Direct funding","2020-06-04","https://ir.novavax.com/news-releases/news-release-details/novavax-awarded-department-defense-contract-covid-19-vaccine"]
["US government","United States of America","United States of America","Novavax",{"v":23000000,"d":"23,000,000.00"},{"v":23,"d":"23.00"},"Direct funding","2020-12-23","https://www.usaspending.gov/award/ASST_NON_UM1AI148685_7529"]
["US government","United States of America","United States of America","Novavax",{"v":21952384,"d":"21,952,384.00"},{"v":21.952384,"d":"21.95"},"Direct funding","2020-06-05","https://www.defense.gov/Newsroom/Contracts/Contract/Article/2210304/"]
["US government","United States of America","United States of America","SAB Biotherapeutics",{"v":27000000,"d":"27,000,000.00"},{"v":27,"d":"27.00"},"Direct funding","2020-01-31","https://sabbiotherapeutics.com/2020/03/31/sab-biotherapeutics-awarded-27m-contract-to-develop-novel-rapid-response-capability-for-u-s-department-of-defense/"]
["US government","United States of America","United States of America","Ology Bioservices",{"v":11900000,"d":"11,900,000.00"},{"v":11.9,"d":"11.90"},"Direct funding","2020-03-24","https://www.ologybio.com/ology-bioservices-inovio-partner-to-manufacture-covid-19-dna-vaccine-with-11-9-million-department-of-defense-grant/"]
["US government","United States of America","Belgium","Janssen",{"v":454310546,"d":"454,310,546.00"},{"v":454.310546,"d":"454.31"},"Direct funding","2020-11-13","https://www.usaspending.gov/award/CONT_IDV_HHSO100201700018C_7505\nhttps://www.nasdaq.com/articles/jj-u.s.-expand-agreement-to-support-next-phase-of-covid-19-vaccine-rd-2020-11-14"]
["US government","United States of America","Belgium","Janssen",{"v":85304775,"d":"85,304,775.00"},{"v":85.304775,"d":"85.30"},"Direct funding","2020-08-20","https://www.usaspending.gov/award/CONT_IDV_HHSO100201700018C_7505"]
["US government","United States of America","Belgium","Janssen",{"v":31998326,"d":"31,998,326.00"},{"v":31.998326,"d":"32.00"},"Direct funding","2021-03-25","https://www.medicalcountermeasures.gov/newsroom/2021/janssen/"]
["US government","United States of America","United States of America","HDT Bio Corp",{"v":8200000,"d":"8,200,000.00"},{"v":8.2,"d":"8.20"},"Direct funding","2020-09-01","https://www.hdt.bio/news"]
["US government","United States of America","United States of America","Soligenix",{"v":1500000,"d":"1,500,000.00"},{"v":1.5,"d":"1.50"},"Direct funding","28/12/2020","http://ir.soligenix.com/2020-12-28-Soligenix-Announces-1-5-Million-NIH-Small-Business-Innovation-Research-Award-Advancing-COVID-19-Vaccine-Development"]
["Vivo Capital","China","China","SinoVac",{"v":7500000,"d":"7,500,000.00"},{"v":7.5,"d":"7.50"},"Direct funding","2020-05-22","https://www.pharmaceutical-technology.com/news/sinovac-covid-19-vaccine-funding/; \nhttps://www.businesswire.com/news/home/20200522005096/en/Sinovac-Secures-15-Million-Funding-Accelerate-COVID-19"]
["Vivo Capital","United States of America","China","SinoVac",{"v":7500000,"d":"7,500,000.00"},{"v":7.5,"d":"7.50"},"Direct funding","2020-05-22","https://www.businesswire.com/news/home/20200522005096/en/Sinovac-Secures-15-Million-Funding-Accelerate-COVID-19"]
["Wellcome Trust","United Kingdom","United Kingdom","Oxford/AstraZeneca",{"v":1575989.0282849802,"d":"1,575,989.03"},{"v":1.5759890282849802,"d":"1.58"},"Direct funding","2020-01-13","https://www.whatdotheyknow.com/request/701825/response/1678268/attach/2/FOI%2020201025%2003%20Ltr%20Funding%20of%20Covid%20vaccine.pdf?cookie_passthrough=1"]

{"sheet":"VaccineRnD legend","index":1,"n_rows":10,"n_cols":2,"rows_kept":10,"flags":["formulas_cached_only"]}
["Column name","Description"]
["Funder","Name of the R&D funder"]
["Funder_Country","Country where the funder is based"]
["Recipient_country","Country where the recipient is based"]
["Recipient_lvl_1","Name of the R&D recipient"]
["Value_USD","Announced investment size  in USD"]
["USD_million","Announced investment size in million USD"]
["Funding_type","Direct funding goes from R&D investor to final recipient (R&D implementer); Secondary funding goes from an intermediary (e.g., CEPI) to the final recipient; Funding to intermediary goes from main R&D investor to an intermediary (e.g., CEPI)"]
["Date announced","As reported by GHC"]
["URL","As reported by GHC"]

{"sheet":"APAs","index":2,"n_rows":21,"n_cols":6,"rows_kept":21,"merged":[[12,4,12,5]],"flags":["formulas_cached_only"]}
["Vaccine developer","Purchaser","USD_million","Date","Notes","URL"]
["Oxford/AstraZeneca","Thailand",469.09,"2020-10-14","The number of doses to be supplied to Thailand was not disclosed. But Prime Minister Prayut Chan-o-cha said on Thursday that the contract was for the purchase of 26 million doses, enough for 13 million people, as each person needs two shots.","https://www.bangkokpost.com/thailand/general/2026547/thailand-signs-deal-with-astrazeneca-for-covid-vaccine"]
["Oxford/AstraZeneca","COVAX",750,"2020-06-04","AstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s potential COVID-19 vaccine, AZD1222, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII).\n The Company today reached a $750m agreement with CEPI and Gavi to support the manufacturing, procurement and distribution of 300 million doses of the potential vaccine, with delivery starting by the end of the year.","https://www.astrazeneca.com/media-centre/articles/2020/astrazeneca-takes-next-steps-towards-broad-and-equitable-access-to-oxford-universitys-potential-covid-19-vaccine.html ; https://s3.amazonaws.com/one.org/vaccine-access-test/ONE_VAT_deal_AstraZeneca_COVAX_EN.pdf; https://www.gavi.org/sites/default/files/covid/covax/COVAX-Interim-Distribution-Forecast.pdf"]
["Oxford/AstraZeneca","Dominican Republic",40,"2020-11-23","The Dominican Republic contracted 10 million doses for US$40 million, already approved last week by the Chamber of Deputies.","https://dominicantoday.com/dr/economy/2020/11/23/ua40m-astrazeneca-vaccines-arrive-feb-official/"]
["Oxford/AstraZeneca","European Union",1060,"2020-08-27"]
["Oxford/AstraZeneca","Indonesia",250,"2020-12-12","The government has made preparations for the procurement of vaccines, and currently, the minister of health and the minister of state enterprises (BUMN) are in the final stage of negotiations with Astra Zeneca, as we are preparing to procure 100 million doses. A down payment of 50 percent, or US$250 million (or around Rp3.7 trillion) is required,\" he stated.","https://en.antaranews.com/news/158753/indonesia-secures-vaccine-supply-for-135-million-people-until-2021;"]
["Oxford/AstraZeneca","Bangladesh",120,"2020-11-05","The COO, Rabbur Reza, said that was about twice the price of around $4 that Beximco had agreed for separate supplies of 5 million doses a month, over the first half of the year, for the Bangladeshi government’s subsidised mass-vaccination programme.","https://www.reuters.com/article/us-health-coronavirus-bangladesh-vaccine/exclusive-bangladeshs-beximco-could-start-private-sales-of-astrazeneca-vaccine-next-month-idUKKBN29H1YC"]
["Oxford/AstraZeneca","Panama",4.3,"2020-11-19","Panama’s government has authorized spending of $4.3 million to purchase 1.09 million doses of a coronavirus vaccine being developed by Britain’s AstraZeneca Plc and Oxford University, the president’s office said on Wednesday.","https://www.reuters.com/article/idUSKBN27Z0F7"]
["Oxford/AstraZeneca","Philippines",12.47,"2020-11-25",null,"https://www.bloomberg.com/news/articles/2020-11-27/philippines-signs-deal-with-astrazeneca-for-2-6-million-doses"]
["Oxford/AstraZeneca","United States",1200,"2020-05-21","$1.2b agreement for development, production and delivery of the vaccine candidate. AZ press release mentions that On the R&D side, the BARDA funding calls for a phase 3 trial in 30,000 participants, plus a pediatric trial.","https://www.fiercepharma.com/pharma/astrazeneca-scores-1b-from-u-s-signs-up-to-deliver-hundreds-millions-covid-19-vaccines ; https://www.astrazeneca.com/media-centre/press-releases/2020/astrazeneca-advances-response-to-global-covid-19-challenge-as-it-receives-first-commitments-for-oxfords-potential-new-vaccine.html"]
["Oxford/AstraZeneca","Brazil",942.65,"2020-06-29","AstraZeneca and the government of Brazil have inked a deal valued at $127 million to produce doses of the University of Oxford's adenovirus-based COVID-19 vaccine candidate, AZD1222, as the country combats a rising count of new infections.","https://www.fiercepharma.com/manufacturing/astrazeneca-to-supply-millions-covid-19-shot-to-brazilian-government-swamped-by-new"]
["Janssen","African Union",2200,"2021-01-14","he African Vaccine Acquisition Task Team (AVATT) established by African Union Chair President Cyril Ramaphosa today reported to a special meeting of the AU Bureau of the Assembly that it has secured a provisional 270 million vaccine doses for African countries, with at least 50 million being available for the crucial period of April to June 2021.","http://www.thepresidency.gov.za/newsletters/africa-centres-disease-control-and-prevention-secures-first-tranche-covid-vaccines\n https://www.news24.com/citypress/business/covid-19-shots-to-cost-3-to-10-under-african-union-vaccine-plan-20210120"]
["Janssen","United States",1000,"2020-08-05","The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) announced an agreement with the Janssen Pharmaceutical Companies of Johnson & Johnson, to demonstrate large-scale manufacturing and delivery of the company’s COVID-19 vaccine candidate. Under the terms of the agreement, the federal government will own the resulting 100 million doses of vaccine.\n \n The vaccine doses could be used in clinical trials or, if the U.S. Food and Drug Administration (FDA) authorizes use as outlined in agency guidance, the doses would be distributed as part of a COVID-19 vaccination campaign."]
["Janssen","European Union",1700,"2020-10-08","Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen’s COVID-19 Vaccine Candidate","https://www.jnj.com/johnson-johnson-announces-european-commission-approval-of-agreement-to-supply-200-million-doses-of-janssens-covid-19-vaccine-candidate ; https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1829 ; https://www.theguardian.com/world/2020/dec/18/belgian-minister-accidentally-tweets-eus-covid-vaccine-price-list"]
["Moderna","United States",4500,"2020-08-11","The Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, collaborated with the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense and Army Contracting Command to provide up to approximately $1.5 billion to manufacture and deliver the vaccine doses to government-designated locations across the country. The government also can acquire up to an additional 400 million doses of the vaccine.","https://www.medicalcountermeasures.gov/newsroom/2020/modernamanufacturing/"]
["Moderna","European Union",2880,"2020-11-25","The commission had previously made a deal for 80 million doses. Moderna's still investigational vaccine requires two doses for each person, spaced one month apart. It has not yet been approved or authorized in any country; however, an emergency use authorization from the Food and Drug Administration is expected at any time. European Union health officials are expected to decide whether to grant a conditional marketing authorization for the vaccine on Jan. 6.","https://investors.modernatx.com/news-releases/news-release-details/european-commission-purchases-additional-150-million-doses-covid#:~:text=This%20brings%20its%20confirmed%20order,Moderna%20and%20our%20mRNA%20platform. ; https://ec.europa.eu/commission/presscorner/detail/en/ip_21_655; https://www.politico.eu/article/commission-to-seal-deal-with-moderna-for-up-to-160m-doses-of-coronavirus-vax/ ; https://www.marketwatch.com/story/eu-to-buy-an-additional-80-million-doses-of-modernas-coronavirus-vaccine-2020-12-18 ; https://www.theguardian.com/world/2020/dec/18/belgian-minister-accidentally-tweets-eus-covid-vaccine-price-list"]
["Novavax","United States",1600,"2020-07-07","$1.6b contract to \"complete late-stage clinical development, including a pivotal Phase 3 clinical trial; establish large-scale manufacturing; and deliver 100 million doses\". The $1.6b contract builds on the previous $60m funding that would also support manufacturing vaccine components and devliery of 10m doses.","https://ir.novavax.com/news-releases/news-release-details/novavax-announces-16-billion-funding-operation-warp-speed"]
["Pfizer/BioNTech","European Union",11340,"2020-11-11","Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses.\n This new agreement is in addition to the 300 million doses that have already been committed to the EU through 2021 under the first supply agreement signed last year. The additional 200 million doses are expected to be delivered in 2021, with an estimated 75 million to be supplied in the second quarter.","https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-supply-european-union-200-million-additional"]
["Pfizer/BioNTech","Israel",352.5,"2020-11-13","As part of the agreement with Pfizer, Netanyahu said Israel would receive 8 million doses of the vaccine, enough to inoculate 4 million Israelis. Netanyahu expressed hope that Pfizer would begin supplying the vaccine in January, pending authorization from health officials in the United States and Israel.","https://www.timesofisrael.com/israel-seals-vaccine-deal-with-pfizer-amid-signs-pandemic-spreading-again/"]
["Pfizer/BioNTech","Panama",84,"2020-11-19","Panama has authorized the purchase of nearly 2 million shots of Pfizer’s COVID-19 vaccine for close to $24 million, adding to earlier agreements to buy 3 million doses from the U.S. drugmaker, the Health Ministry said on Sunday.","https://www.reuters.com/article/health-coronavirus-panama/panama-to-buy-2-million-more-doses-of-pfizer-vaccine-idUSL2N2KY0LQ"]
["Pfizer/BioNTech","United States",5972.48,"2020-07-22","The Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, collaborated with the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense and Army Contracting Command, to provide $1.95 billion for the production and nationwide delivery of the first 100 million doses of the vaccine after EUA or licensure, with the ability to acquire up to an additional 500 million doses.","https://www.medicalcountermeasures.gov/newsroom/2020/pfizer/"]